How do I find out if I qualify for a metastatic urothelial carcinoma study in Illinois?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in Illinois to take part?

Not necessarily. These studies have a site in Illinois, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a metastatic urothelial carcinoma trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · Illinois

Metastatic Urothelial Carcinoma clinical trials in Illinois

We’re tracking 26 recruiting metastatic urothelial carcinoma studies with a site in Illinois — including Phase 1/Phase 2 and Phase 2 studies, each written for real people, not researchers.

Recruiting studies in Illinois

NCT04104776RecruitingPhase 1/Phase 2
Test drug tulmimetostat for advanced cancers and lymphomas
This early-phase study tests tulmimetostat (DZR123) to shrink or control advanced solid tumors and certain lymphomas, and it may also test a combination in some prostate cancer groups. If you qualify, you’ll receive the study drug and be monitored closely, including blood tests and a request for tumor tissue to look for biomarkers.
Maywood, IllinoisAges 18 years+
NCT06172478RecruitingPhase 2
HER3-DXd for advanced solid tumors after prior treatment
This trial tests a new targeted drug called HER3-DXd for people with several types of advanced solid tumors that have stopped responding to standard treatments. The drug is an antibody-drug conjugate, designed to deliver chemotherapy directly to cancer cells that have a protein called HER3 on their surface.
Chicago, IllinoisAges 18 years+

Metastatic Urothelial Carcinoma trials by city in Illinois

Chicago

Where these studies are running in Illinois

Institutions with a site for the recruiting metastatic urothelial carcinoma studies listed above.

Loyola University Medical Center
University of Chicago Medical Center
University of Illinois Cancer Center

What taking part in a metastatic urothelial carcinoma study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Metastatic Urothelial Carcinoma trials in other states

Common questions

Are there metastatic urothelial carcinoma clinical trials in Illinois?: Yes. We're currently tracking 26 recruiting metastatic urothelial carcinoma studies with a site in Illinois, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a metastatic urothelial carcinoma study in Illinois?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in Illinois to take part?: Not necessarily. These studies have a site in Illinois, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a metastatic urothelial carcinoma trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New metastatic urothelial carcinoma studies open in Illinois regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.